Aptevo Therapeutics APVO
NASDAQ APVO
$1.82 -0.04 (-2.15%)
At close: Sep 30, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Tax Provisions (2015 - 2019)

Updated

Aptevo Therapeutics (APVO) reported Tax Provisions of -$999,000 for Q3 2019.

Analysis

Aptevo Therapeutics (APVO) Tax Provisions (2015 - 2019) Analysis & Trends

Over the twelve months ended Sep 30, 2019, Aptevo Therapeutics' Tax Provisions came in at -$23.48 million; for FY2017, it was -$23.3 million.

  • By year, Tax Provisions came in at -$19.69 million in FY2016 and -$2.02 million in FY2015.
  • The Q3 2019 figure ranks as the highest quarterly Tax Provisions since Q2 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 Aptevo Therapeutics 2.58 Mn -64.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -999,000.00
Dec 31, 2017 -7.71 Mn
Sep 30, 2017 -13.77 Mn
Jun 30, 2017 -996,000.00
Mar 31, 2017 -823,000.00
Dec 31, 2016 -1.10 Mn
Sep 30, 2016 -17.61 Mn
Jun 30, 2016 -11,000.00
Mar 31, 2016 -12,000.00
Dec 31, 2015 -610,000.00
Sep 30, 2015 -424,000.00
Jun 30, 2015 -612,000.00
API Access

Aptevo Therapeutics Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=APVO&period=max&api_key=YOUR_API_KEY